Xinxin Liu is a global pharmaceutical analytics leader with extensive experience in strategy and operations across both startup and Fortune 500 companies. They have a proven background in strategic forecasting and analytics across various therapeutic areas, including Oncology, Inflammation and Immunology, and Rare Disease. Currently serving as the Director of Commercial Excellence for Pfizer's Rare Disease Portfolio, Xinxin provides strategic insight and commercial planning, guiding sales strategies and innovation initiatives. Previously, they held pivotal roles in analytics and forecasting at AstraZeneca and Sunovion Pharmaceuticals, enhancing their expertise in managed market analytics and business assessments. Xinxin earned a Master of Science in Statistics from Virginia Commonwealth University and a Master's in Financial Economics from Kent State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices